Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Capital Leases (2018)

Historic Capital Leases for Regenxbio (RGNX) over the last 1 years, with Q4 2018 value amounting to $5.9 million.

  • Regenxbio's Capital Leases changed N/A to $5.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $5.9 million, marking a year-over-year change of. This contributed to the annual value of $5.9 million for FY2018, which is N/A changed from last year.
  • Per Regenxbio's latest filing, its Capital Leases stood at $5.9 million for Q4 2018.
  • In the past 5 years, Regenxbio's Capital Leases ranged from a high of $5.9 million in Q4 2018 and a low of $5.9 million during Q4 2018